Ingram Micro Holding Corporation(INGM) - 2025 Q4 - Earnings Call Presentation
2026-03-02 22:00
Ingram Micro Q4 and Full Year 2025 Earnings Supplement A Year of Growth and Innovation Proprietary information of Ingram Micro — Do not distribute or duplicate without Ingram Micro's express written permission. 1 | | | Q4 2025 | Y/Y Growth (1) | | --- | --- | --- | --- | | Net Sales ($B) | $ | 14.9 | +11.5% | | Gross Profit ($M) | $ | 966 | +3.2% | | Adjusted Income from Operations(2) ($M) | $ | 350 | +14.7% | | Non-GAAP Net Income(2) ($M) | $ | 227 | +6.4% | | Non-GAAP Diluted EPS(2) ($) | $ | 0.96 | +4.3% ...
Life360, Inc.(LIF) - 2025 Q4 - Earnings Call Presentation
2026-03-02 22:00
FY'25 Investor Presentation For personal use only 2 March 2026 U.S. PT | 3 March 2026 AEDT Investor Presentation | March 2026 DISCLAIMER These materials and the accompanying oral presentation have been prepared by Life360, Inc. (ARBN 629 412 942) ("Company") on a confidential and non-reliance basis, and may not be reproduced in whole or in part, nor may any of its contents be disclosed, to any other person, without the prior written consent of the Company. These materials are for informational purposes only ...
BigBear.ai(BBAI) - 2025 Q4 - Earnings Call Presentation
2026-03-02 21:30
Investor Presentation Fourth Quarter 2025 Kevin McAleenan Chief Executive Officer, Board Member Sean Ricker Chief Financial Officer © 2026 BigBear.ai, All rights reserved | BigBear.ai Proprietary. 1 Non-GAAP Financial Information This presentation includes financial measures that are not in accordance with generally accepted accounting principles ("GAAP"), such as EBITDA, Adjusted EBITDA, and Adjusted Gross Margin. We believe these non-GAAP financial measures provide investors and analysts with useful suppl ...
Asana(ASAN) - 2026 Q4 - Earnings Call Presentation
2026-03-02 21:30
Q4'26 Asana Investor Overview Forward-Looking Statements This presentation and the accompanying oral presentation include express and implied "forward-looking statementsˮ within the meaning of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding our financial outlook, product development, business strategy and plans, and market trends, opportunities and positioning. These forward-looking statements are based on current expectations, estimates, forecasts an ...
Riot Platforms(RIOT) - 2025 Q4 - Earnings Call Presentation
2026-03-02 21:30
RIOT PLATFORMS FY 2025 EARNINGS | March 2, 2026 NASDAQ: RIOT Conceptual rendering FORWARD- LOOKING STATEMENT Statements in this presentation that are not statements of historical fact are for- ward-looking statements that reflect management's current expectations, assump- tions, and estimates of future performance and economic conditions, and are not guarantees of future performance or actual results. Such statements are made in reliance on the safe harbor provisions of Section 27A of the Securities Act of ...
Quanterix(QTRX) - 2025 Q4 - Earnings Call Presentation
2026-03-02 21:30
Legal Information Fourth Quarter & Full Year 2025 Earnings Presentation March 2, 2026 1 CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS Statements included in this presentation that are not historical in nature or do not relate to current facts are intended to be, and are hereby identified as, forward-looking statements for purposes of the safe harbor provided by Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looki ...
Belite Bio(BLTE) - 2025 Q4 - Earnings Call Presentation
2026-03-02 21:30
Q4 and FYE 2025 Financial Results Conference Call March 2, 2026, 4:30 p.m. ET Nasdaq: BLTE For more info, please visit: www.belitebio.com Belite Bio Participants Belite Management Team Hao-Yuan Chuang, CFA, MBA, FRM (CFO) B E L I T E B I O / 2 Tom Lin, MMED, PhD, MBA (Chairman, CEO) Hendrik Scholl, MD, MA (CMO) Nathan Mata, PhD (CSO) • 16+ years of executive management roles in biotech • Over 10 new drug developments in multiple therapeutic areas including ophthalmology • University of Sydney, University of ...
Pampa Energia(PAM) - 2025 Q4 - Earnings Call Presentation
2026-03-02 21:30
Q4 2025 March 2, 2026 @ 4:30 PM EST/6:30 PM ART RESULTS CALL DISCLAIMER The material that follows is a presentation of general background information about Pampa Energía S.A.("Pampa" or the "Company") as of the date of the presentation . It is information in summary form and does not purport to be complete . It is not intended to be relied upon as advice to potential investors. This presentation is strictly confidential and may not be disclosed to any other person. No representation or warranty, express or ...
Core Scientific(CORZ) - 2025 Q4 - Earnings Call Presentation
2026-03-02 21:30
Fourth Quarter Fiscal 2025 Earnings Call March 2, 2026 1 FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended, (the "Exchange Act"). Forward-looking statements may include words such as "aim," "estimate," "plan," "project," "forecast," "goal," "intend," "will," "expect," "anticipate," "believe," "seek," "target" or ...
Ameresco(AMRC) - 2025 Q4 - Earnings Call Presentation
2026-03-02 21:30
Q4 2025 Supplemental Information March 2, 2026 ameresco.com © 2025 Ameresco, Inc. All rights reserved. Safe Harbor Forward Looking Statements Any statements in this presentation about future expectations, plans and prospects for Ameresco, Inc., including statements about market conditions, pipeline, visibility, backlog, pending agreements, new and expanding market opportunities, financial guidance including estimated future revenues, net income, adjusted EBITDA, Non-GAAP EPS, gross margin, effective tax rat ...